Loading viewer...
presentation
Format: PDF presentation
This presentation discusses the PRECISION-1 trial evaluating nab-sirolimus for advanced malignancies with TSC1 and TSC2 alterations, highlighting its efficacy and safety.
37 Pages
presentation
Seven Group
presentation
Molecular Partners
presentation
Imperial Brands
presentation
William Blair & Company